Literature DB >> 22171010

Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth.

Seungwoon Seo1, Hardeep P Singh, Pedro M Lacal, Amy Sasman, Anees Fatima, Ting Liu, Kathryn M Schultz, Douglas W Losordo, Ordan J Lehmann, Tsutomu Kume.   

Abstract

Normal vision requires the precise control of vascular growth to maintain corneal transparency. Here we provide evidence for a unique mechanism by which the Forkhead box transcription factor FoxC1 regulates corneal vascular development. Murine Foxc1 is essential for development of the ocular anterior segment, and in humans, mutations have been identified in Axenfeld-Rieger syndrome, a disorder characterized by anterior segment dysgenesis. We show that FOXC1 mutations also lead to corneal angiogenesis, and that mice homozygous for either a global (Foxc1(-/-)) or neural crest (NC)-specific (NC-Foxc1(-/-)) null mutation display excessive growth of corneal blood and lymphatic vessels. This is associated with disorganization of the extracellular matrix and increased expression of multiple matrix metalloproteinases. Heterozygous mutants (Foxc1(+/-) and NC-Foxc1(+/-)) exhibit milder phenotypes, such as disrupted limbal vasculature. Moreover, environmental exposure to corneal injury significantly increases growth of both blood and lymphatic vessels in both Foxc1(+/-) and NC-Foxc1(+/-) mice compared with controls. Notably, this amplification of the angiogenic response is abolished by inhibition of VEGF receptor 2. Collectively, these findings identify a role for FoxC1 in inhibiting corneal angiogenesis, thereby maintaining corneal transparency by regulating VEGF signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171010      PMCID: PMC3277512          DOI: 10.1073/pnas.1109540109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

Review 1.  Corneal neovascularization.

Authors:  J H Chang; E E Gabison; T Kato; D T Azar
Journal:  Curr Opin Ophthalmol       Date:  2001-08       Impact factor: 3.761

2.  Sustained inhibition of corneal neovascularization by genetic ablation of CCR5.

Authors:  Balamurali K Ambati; Akshay Anand; Antonia M Joussen; William A Kuziel; Anthony P Adamis; Jayakrishna Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

Review 3.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

Review 4.  Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman.

Authors:  Birgit Regenfuss; Felix Bock; Anand Parthasarathy; Claus Cursiefen
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

5.  The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25.

Authors:  D Y Nishimura; R E Swiderski; W L Alward; C C Searby; S R Patil; S R Bennet; A B Kanis; J M Gastier; E M Stone; V C Sheffield
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

Review 6.  The evolution of Fox genes and their role in development and disease.

Authors:  Sridhar Hannenhalli; Klaus H Kaestner
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

Review 7.  Current molecular understanding and future treatment strategies for pathologic ocular neovascularization.

Authors:  Michael J Tolentino
Journal:  Curr Mol Med       Date:  2009-11       Impact factor: 2.222

8.  FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.

Authors:  Aamir Ahmad; Zhiwei Wang; Dejuan Kong; Shadan Ali; Yiwei Li; Sanjeev Banerjee; Raza Ali; Fazlul H Sarkar
Journal:  Breast Cancer Res Treat       Date:  2009-10-08       Impact factor: 4.872

9.  Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.

Authors:  Aslaug Aa Muggerud; Jo Anders Rønneberg; Fredrik Wärnberg; Johan Botling; Florence Busato; Jovana Jovanovic; Hiroko Solvang; Ida Bukholm; Anne-Lise Børresen-Dale; Vessela N Kristensen; Therese Sørlie; Jörg Tost
Journal:  Breast Cancer Res       Date:  2010-01-07       Impact factor: 6.466

10.  Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells.

Authors:  Hisaki Hayashi; Tsutomu Kume
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

View more
  41 in total

1.  Studies on Axenfeld-Rieger syndrome patients and mice reveal Foxc1's role in corneal neovascularization.

Authors:  Mathias François; Ramani Ramchandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?

Authors:  Anne Joutel; Iman Haddad; Julien Ratelade; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  FOXC1-associated phenotypes in humans may not always exhibit corneal neovascularization.

Authors:  Subhabrata Chakrabarti; Muralidhar Ramappa; Sunita Chaurasia; Inderjeet Kaur; Anil K Mandal
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-11       Impact factor: 11.205

4.  Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia.

Authors:  Ramzi Abboud; Se Young Han; Eric J Duncavage; Amanda F Cashen; Cara Lunn Shirai; John S Welch; John F DiPersio; Camille N Abboud
Journal:  Haematologica       Date:  2019-02-07       Impact factor: 9.941

5.  Tissue Engineering of Axially Vascularized Soft-Tissue Flaps with a Poly-(ɛ-Caprolactone) Nanofiber-Hydrogel Composite.

Authors:  Dominic Henn; Kellen Chen; Katharina Fischer; Annika Rauh; Janos A Barrera; Yoo-Jin Kim; Russell A Martin; Matthias Hannig; Patricia Niedoba; Sashank K Reddy; Hai-Quan Mao; Ulrich Kneser; Geoffrey C Gurtner; Justin M Sacks; Volker J Schmidt
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-10       Impact factor: 4.730

6.  Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease.

Authors:  Curtis R French; Sudha Seshadri; Anita L Destefano; Myriam Fornage; Corey R Arnold; Philip J Gage; Jonathan M Skarie; William B Dobyns; Kathleen J Millen; Ting Liu; William Dietz; Tsutomu Kume; Marten Hofker; Derek J Emery; Sarah J Childs; Andrew J Waskiewicz; Ordan J Lehmann
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

Review 7.  New insights into mononuclear phagocyte biology from the visual system.

Authors:  Nancy J Reyes; Emily G O'Koren; Daniel R Saban
Journal:  Nat Rev Immunol       Date:  2017-03-27       Impact factor: 53.106

8.  Organogenesis and distribution of the ocular lymphatic vessels in the anterior eye.

Authors:  Yifan Wu; Young Jin Seong; Kin Li; Dongwon Choi; Eunkyung Park; George H Daghlian; Eunson Jung; Khoa Bui; Luping Zhao; Shrimika Madhavan; Saren Daghlian; Patill Daghlian; Desmond Chin; Il-Taeg Cho; Alex K Wong; Martin Heur; Sandy Zhang-Nunes; James C Tan; Masatsugu Ema; Tina T Wong; Alex S Huang; Young-Kwon Hong
Journal:  JCI Insight       Date:  2020-07-09

9.  Conditional inactivation of Foxc1 and Foxc2 in neural crest cells leads to cardiac abnormalities.

Authors:  Joshua Sanchez; Risa Miyake; Andrew Cheng; Ting Liu; Sachiko Iseki; Tsutomu Kume
Journal:  Genesis       Date:  2020-04-07       Impact factor: 2.487

Review 10.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.